A detailed history of Capital Research Global Investors transactions in Alcon Inc stock. As of the latest transaction made, Capital Research Global Investors holds 411,203 shares of ALC stock, worth $41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
411,203
Previous 412,279 0.26%
Holding current value
$41 Million
Previous $34.3 Million 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$77.58 - $92.26 $83,476 - $99,271
-1,076 Reduced 0.26%
411,203 $36.6 Million
Q1 2024

May 14, 2024

BUY
$74.84 - $88.15 $2.84 Million - $3.34 Million
37,932 Added 10.13%
412,279 $34.3 Million
Q4 2023

Feb 13, 2024

BUY
$69.57 - $78.12 $22.7 Million - $25.5 Million
325,804 Added 671.17%
374,347 $29.2 Million
Q3 2023

Nov 13, 2023

SELL
$76.74 - $85.2 $411,479 - $456,842
-5,362 Reduced 9.95%
48,543 $3.74 Million
Q2 2023

Aug 11, 2023

BUY
$69.16 - $82.11 $3.73 Million - $4.43 Million
53,905 New
53,905 $4.43 Million
Q4 2022

Feb 14, 2023

SELL
$56.51 - $71.71 $7.65 Million - $9.7 Million
-135,318 Reduced 9.22%
1,332,543 $91.3 Million
Q3 2022

Nov 14, 2022

SELL
$56.96 - $78.09 $1.19 Million - $1.64 Million
-20,969 Reduced 1.41%
1,467,861 $85 Million
Q2 2022

Aug 15, 2022

SELL
$64.25 - $81.25 $149 Million - $188 Million
-2,316,350 Reduced 60.87%
1,488,830 $104 Million
Q1 2022

May 16, 2022

SELL
$71.65 - $87.13 $78.2 Million - $95.1 Million
-1,091,245 Reduced 22.29%
3,805,180 $301 Million
Q4 2021

Feb 14, 2022

BUY
$77.91 - $88.5 $391,653 - $444,889
5,027 Added 0.1%
4,896,425 $434 Million
Q3 2021

Nov 15, 2021

SELL
$68.18 - $87.25 $737,434 - $943,696
-10,816 Reduced 0.22%
4,891,398 $396 Million
Q2 2021

Aug 16, 2021

SELL
$66.27 - $76.21 $37.1 Million - $42.6 Million
-559,491 Reduced 10.24%
4,902,214 $343 Million
Q1 2021

May 14, 2021

SELL
$65.32 - $76.01 $88.2 Million - $103 Million
-1,350,715 Reduced 19.83%
5,461,705 $382 Million
Q4 2020

Feb 12, 2021

SELL
$56.82 - $66.57 $485 Million - $568 Million
-8,530,567 Reduced 55.6%
6,812,420 $455 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $62.39 $203 Million - $230 Million
-3,681,431 Reduced 19.35%
15,342,987 $871 Million
Q2 2020

Aug 14, 2020

SELL
$49.45 - $64.16 $441 Million - $572 Million
-8,914,020 Reduced 31.91%
19,024,418 $1.09 Billion
Q1 2020

May 15, 2020

SELL
$39.86 - $63.46 $155 Million - $247 Million
-3,886,104 Reduced 12.21%
27,938,438 $1.43 Billion
Q4 2019

Feb 18, 2020

BUY
$55.04 - $59.27 $604 Million - $650 Million
10,970,060 Added 52.6%
31,824,542 $1.8 Billion
Q3 2019

Nov 14, 2019

BUY
$58.2 - $62.42 $8.33 Million - $8.93 Million
143,044 Added 0.69%
20,854,482 $1.22 Billion
Q2 2019

Aug 14, 2019

BUY
$54.43 - $63.33 $1.13 Billion - $1.31 Billion
20,711,438 New
20,711,438 $1.28 Billion

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $48.9B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.